Evofem Biosciences, Inc.
OTC: EVFM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Saundra Pelletier
- Employees
- 32
- Headquarters
- San Diego, United States
- IPO year
- 2014
- Market cap
- $1.1M
- Website
- https://www.evofem.com
Loading EVFM…
Loading profile data…Frequently asked questions about EVFM
What does Evofem Biosciences, Inc. (EVFM) do?
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively...
Where does EVFM trade?
Evofem Biosciences, Inc. (EVFM) trades on the Other OTC.
What sector is EVFM in?
Evofem Biosciences, Inc. (EVFM) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Evofem Biosciences, Inc.?
Saundra Pelletier is the chief executive officer of Evofem Biosciences, Inc. (EVFM).
Where is Evofem Biosciences, Inc. headquartered?
Evofem Biosciences, Inc. is headquartered in United States.
Does EVFM pay a dividend?
Evofem Biosciences, Inc. (EVFM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EVFM go public?
Evofem Biosciences, Inc. (EVFM) completed its initial public offering in 2014.